These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 21996467

  • 1. Synthesis and biological activity of new bispyridinium salts of 4,4'-bispyridyl-5,5'-perfluoroalkyl-2,2'-bisoxazoles.
    Martín-Cantalejo Y, Sáez B, Monterde MI, Murillo MT, Braña MF.
    Eur J Med Chem; 2011 Nov; 46(11):5662-7. PubMed ID: 21996467
    [Abstract] [Full Text] [Related]

  • 2. Bispyridinium cyclophanes: novel templates for human choline kinase inhibitors.
    Conejo-García A, Campos JM, Sánchez-Martín RM, Gallo MA, Espinosa A.
    J Med Chem; 2003 Aug 14; 46(17):3754-7. PubMed ID: 12904080
    [Abstract] [Full Text] [Related]

  • 3. A novel 4,4'-bispyridyl-5,5'-perfluoroalkyl-2,2'-bisoxazol with antitumoral activity via cell cycle arrest and induction of apoptosis.
    Báñez-Coronel M, Rodríguez-González A, Martín-Cantalejo Y, Sáez B, Soto J, Villa MJ, Braña MF, Lacal JC.
    Int J Oncol; 2004 Oct 14; 25(4):1097-103. PubMed ID: 15375561
    [Abstract] [Full Text] [Related]

  • 4. Influence of the linker in bispyridium compounds on the inhibition of human choline kinase.
    Conejo-García A, Báñez-Coronel M, Sánchez-Martín RM, Rodríguez-González A, Ramos A, Ramírez de Molina A, Espinosa A, Gallo MA, Campos JM, Lacal JC.
    J Med Chem; 2004 Oct 21; 47(22):5433-40. PubMed ID: 15481981
    [Abstract] [Full Text] [Related]

  • 5. New non-symmetrical choline kinase inhibitors.
    Schiaffino-Ortega S, López-Cara LC, Ríos-Marco P, Carrasco-Jimenez MP, Gallo MA, Espinosa A, Marco C, Entrena A.
    Bioorg Med Chem; 2013 Nov 15; 21(22):7146-54. PubMed ID: 24080101
    [Abstract] [Full Text] [Related]

  • 6. Choline kinase inhibitors as a novel approach for antiproliferative drug design.
    Hernández-Alcoceba R, Saniger L, Campos J, Núñez MC, Khaless F, Gallo MA, Espinosa A, Lacal JC.
    Oncogene; 1997 Nov 06; 15(19):2289-301. PubMed ID: 9393874
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and antiproliferative evaluation of some new amidino-substituted bis-benzothiazolyl-pyridines and pyrazine.
    Racané L, Kraljević Pavelić S, Ratkaj I, Stepanić V, Pavelić K, Tralić-Kulenović V, Karminski-Zamola G.
    Eur J Med Chem; 2012 Sep 06; 55():108-16. PubMed ID: 22841279
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and biological testing of novel pyridoisothiazolones as histone acetyltransferase inhibitors.
    Furdas SD, Shekfeh S, Bissinger EM, Wagner JM, Schlimme S, Valkov V, Hendzel M, Jung M, Sippl W.
    Bioorg Med Chem; 2011 Jun 15; 19(12):3678-89. PubMed ID: 21353783
    [Abstract] [Full Text] [Related]

  • 9. Novel 4-amino bis-pyridinium and bis-quinolinium derivatives as choline kinase inhibitors with antiproliferative activity against the human breast cancer SKBR-3 cell line.
    Gómez-Pérez V, McSorley T, See Too WC, Konrad M, Campos JM.
    ChemMedChem; 2012 Apr 15; 7(4):663-9. PubMed ID: 22278967
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. QSAR-derived choline kinase inhibitors: how rational can antiproliferative drug design be?
    Campos J, Núñez MC, Conejo-García A, Sánchez-Martín RM, Hernández-Alcoceba R, Rodríguez-González A, Lacal JC, Gallo MA, Espinosa A.
    Curr Med Chem; 2003 Jul 15; 10(13):1095-112. PubMed ID: 12678804
    [Abstract] [Full Text] [Related]

  • 15. A new family of choline kinase inhibitors with antiproliferative and antitumor activity derived from natural products.
    Estévez-Braun A, Ravelo AG, Pérez-Sacau E, Lacal JC.
    Clin Transl Oncol; 2015 Jan 15; 17(1):74-84. PubMed ID: 25472447
    [Abstract] [Full Text] [Related]

  • 16. An expeditious synthesis and anticancer activity of novel 4-(3'-indolyl)oxazoles.
    Kumar D, Kumar NM, Sundaree S, Johnson EO, Shah K.
    Eur J Med Chem; 2010 Mar 15; 45(3):1244-9. PubMed ID: 20047778
    [Abstract] [Full Text] [Related]

  • 17. In vivo antitumor activity of choline kinase inhibitors: a novel target for anticancer drug discovery.
    Hernández-Alcoceba R, Fernández F, Lacal JC.
    Cancer Res; 1999 Jul 01; 59(13):3112-8. PubMed ID: 10397253
    [Abstract] [Full Text] [Related]

  • 18. Design, synthesis, theoretical calculations and biological evaluation of new non-symmetrical choline kinase inhibitors.
    Rubio-Ruíz B, Conejo-García A, Ríos-Marco P, Carrasco-Jiménez MP, Segovia J, Marco C, Gallo MA, Espinosa A, Entrena A.
    Eur J Med Chem; 2012 Apr 01; 50():154-62. PubMed ID: 22348828
    [Abstract] [Full Text] [Related]

  • 19. 5-Substituted [1]pyrindine derivatives with antiproliferative activity.
    Kolb S, Goddard ML, Loukaci A, Mondésert O, Ducommun B, Braud E, Garbay C.
    Eur J Med Chem; 2010 Mar 01; 45(3):896-901. PubMed ID: 19969400
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.